Page 2 - எடுப்போசை ஆன் நாள்பட்ட கல்லீரல் தோல்வி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எடுப்போசை ஆன் நாள்பட்ட கல்லீரல் தோல்வி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எடுப்போசை ஆன் நாள்பட்ட கல்லீரல் தோல்வி Today - Breaking & Trending Today

Global Acute On Chronic Liver Failure (ACLF) Market Insight, Epidemiology and Market Forecast to 2030


Global Acute On Chronic Liver Failure (ACLF) Market Insight, Epidemiology and Market Forecast to 2030
Read full article
March 10, 2021, 1:28 AM·5 min read
ResearchAndMarkets.com s offering.
This report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of acute-on-chronic liver failure (ACLF) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The acute-on-chronic liver failure (ACLF) market report provides analysis regarding current treatment practices, emerging drugs like Albutein 5% (PE-A 5%) and Hepastem, other promising therapies market share of the individual therapies, and historical, current, and forecasted ACLF market size from 2017 to 2030, segmented by seven major markets. ....

Market Size , Liver Failure , Acute On Chronic Liver Failure , சந்தை அளவு , கல்லீரல் தோல்வி , எடுப்போசை ஆன் நாள்பட்ட கல்லீரல் தோல்வி ,

International research network identifies triggers for severe course of liver cirrhosis


 E-Mail
FRANKFURT. Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently. When the body is no longer able to compensate for the liver s declining performance, the condition deteriorates dramatically in a very short time: tissue fluid collects in the abdomen (ascites), internal bleeding occurs in the oesophagus and elsewhere, and the brain is at risk of being poisoned by metabolic products. This acute decompensation of liver cirrhosis can develop into acute-on-chronic liver failure with inflammatory reactions throughout the body and failure of several organs.
In the PREDICT study, led by Professor Jonel Trebicka, scientists from 15 European countries observed 1273 patients who were hospitalized with acute decompensation of their liver cirrhosis. The current evaluation of the study focused on the question of what can trigger acute decompensation of liver cirrhosis. The result: in the va ....

Jonel Trebicka , Clif Consortium , European University Hospitals , University Hospital Frankfurt , Easl Clif Consortium , Professor Jonel Trebicka , European Foundation , Chronic Liver , Chronic Liver Failure , Acute On Chronic Liver Failure , University Hospitals , Grifols Chair , European Network , Translational Research , கிளிஃப் கூட்டமைப்பு , ஐரோப்பிய பல்கலைக்கழகம் மருத்துவமனைகள் , பல்கலைக்கழகம் மருத்துவமனை பிராங்க்ஃபர்ட் , ஐரோப்பிய அடித்தளம் , நாள்பட்ட கல்லீரல் , நாள்பட்ட கல்லீரல் தோல்வி , எடுப்போசை ஆன் நாள்பட்ட கல்லீரல் தோல்வி , பல்கலைக்கழகம் மருத்துவமனைகள் , கிரிஃபோல்கள் நாற்காலி , ஐரோப்பிய வலைப்பின்னல் , மொழிபெயர்ப்பு ஆராய்ச்சி ,